Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This indicates a minor page refresh or metadata update on the study details page without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-21T12:50:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The revision label on the page updated to v3.6.3, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:34.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended, indicating the trial is not enrolling any more participants. Added navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a site revision label (Revision: v3.6.0); the header formatting around Intervention/Treatment was updated.
    Difference
    0.6%
    Check dated 2026-06-15T19:00:44.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5. This indicates a behind-the-scenes update to the study page's software or content management system.
    Difference
    0.1%
    Check dated 2026-06-08T15:24:22.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This indicates a minor patch to the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:53:24.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    This updates the ClinicalTrials.gov page’s visible revision/version label from v3.5.2 to v3.5.3 without changing any underlying study details.
    Difference
    0.1%
    Check dated 2026-04-26T15:25:13.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.